Innova Captab

New Jammu Facility Will Capture Global Healthcare Demand

AnalystConsensusTarget

Not Invested

Consensus Narrative from 2 Analysts

Published

06 Sep 25

AnalystConsensusTarget's Fair Value

₹1,076.00

20.0% undervalued

06 Sep

₹861.10

8.3%

0.2%

8.3%

0.2%

You can edit this narrative until Sep 6 8:09 PM. Then, changes will post as Updates.

Author's Valuation

₹1.1k

20.0% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

₹1.08k

20.0% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

25.03%

Life Sciences revenue growth rate

0.31%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

13.60%

Calculation

₹3.35b

Earnings '28

26.84x

PE Ratio '28

₹89.87b

Market Cap '28

₹89.87b

Market Cap '28

57.30m

No. shares '28

₹1.57k

Share Price '28

₹1.57k Share Price '28

Discounted to 2025 @ 13.58% p.a.

₹1.07k

Fair Value '25